Developer of targeted therapy drugs designed for the treatment of hematologic cancers. The company leverages advances in molecular genetics and biology to develop new classes of therapies that are hig...

Healthcare
New York, NY, United States
Founded 2019
9 employees
Website
Valuation
$192.5M
Latest known
Share Price
N/A
Total Raised
$143M
Last Round
N/A